Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
Izabela Krauze1,2, Beata Greb-Markiewicz2, Anna Kłopot1
1Department of Biochemistry and Immunochemistry, Wroclaw Medical University, Wroclaw, Poland.
Abstract:
Cancer is the second leading cause of global mortality after cardiovascular diseases, with breast, lung, colon, and prostate cancers being the most common. WHO projects around 30 million new cancer cases worldwide by 2045, with breast cancer being the most common in women and lung cancer in men. Metastasis is responsible for nearly 90% of cancer-related deaths. Breast and lung cancers tend to metastasize to the bones, lymph nodes, lungs, liver, and brain. Lungs remains one of the most common organs to which various forms of cancer metastasize. An important factor in metastasis is NETosis - it can initially help to eliminate cancer cells, but it can also promote metastasis. Phytocannabinoids, compounds derived from Cannabis sativa, and the endocannabinoid system (ECS) offer promising therapeutic potential to inhibit NETosis and consequently cancer development and metastasis. Although the precise effects of phytocannabinoids on neutrophil functions and NETosis are not fully understood and require further research in the context of cancer, preliminary studies suggest their potential to inhibit NET release in various disease models. This review consolidates current knowledge and provides new insights into how phytocannabinoids and the ECS may serve as effective therapeutic tools to limit cancer metastasis.
Insights
Phytocannabinoids and the endocannabinoid system (ECS) show promise in inhibiting NETosis, a process that can drive cancer metastasis. This research explores their potential to limit cancer spread and improve outcomes.
Area of Science:
- Oncology
- Pharmacology
- Immunology
Background:
- Cancer is a leading cause of death, with metastasis responsible for 90% of fatalities.
- Lung and breast cancers commonly metastasize to organs like the lungs, liver, and brain.
- NETosis, a neutrophil process, can paradoxically promote cancer metastasis.
Purpose of the Study:
- To review the current knowledge on phytocannabinoids and the endocannabinoid system (ECS) in cancer.
- To explore the potential of phytocannabinoids and ECS to inhibit NETosis and cancer metastasis.
- To provide insights into novel therapeutic strategies for limiting cancer metastasis.
Main Methods:
- Literature review consolidating current research on phytocannabinoids, ECS, NETosis, and cancer metastasis.
- Analysis of preliminary studies on phytocannabinoid effects on neutrophil function and NETosis.
- Exploration of the role of ECS in regulating NETosis in cancer contexts.
Main Results:
- Phytocannabinoids, derived from Cannabis sativa, and the ECS show therapeutic potential.
- Preliminary data suggest phytocannabinoids can inhibit NET release in various disease models.
- The precise mechanisms of phytocannabinoids on neutrophil functions and NETosis in cancer require further investigation.
Conclusions:
- Phytocannabinoids and the ECS may offer a promising therapeutic avenue to inhibit cancer metastasis.
- Targeting NETosis with phytocannabinoids could be a novel strategy to combat cancer progression.
- Further research is needed to fully elucidate the role of phytocannabinoids and ECS in cancer metastasis.
More Related Videos
07:36Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues
Published on: August 18, 2023
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
The Tumor Microenvironment
Selectins
Cancer Cell Migration through Invadopodia
Drugs that Stabilize Microtubules
